سعر ميراج 500 مجم فيال للحقن الوريدي 2026

Meropenem 500 mg powder for IV injection/infusion with sodium carbonate, Adwia (Misr), Egypt.

• Severe pneumonia, including hospital-acquired and ventilator-associated pneumonia.Population: Adults and children over 3 monthsAdwia (Misr)
• Broncho-pulmonary infections in cystic fibrosis.Population: Adults and children over 3 monthsAdwia (Misr)
• Complicated urinary tract infections.Population: Adults and children over 3 monthsAdwia (Misr)

• Common: diarrhoea, nausea/vomiting, rash, injection-site inflammation, headache, thrombocythaemia, increased liver enzymes/alkaline phosphatase/LDH. Uncommon: candidiasis, eosinophilia, neutropenia, thrombocytopenia, anaphylaxis, antibiotic-associated colitis, SJS/TEN, creatinine increased.International label, same formulation · Medicines.org.uk (eMC) / MHRA

• Hypersensitivity to meropenem or excipients; hypersensitivity to any other carbapenem; severe hypersensitivity (e.g. anaphylaxis, severe skin reaction) to any other beta-lactam (penicillins, cephalosporins).International label, same formulation · Medicines.org.uk (eMC) / MHRA

• Select carbapenem use considering severity, local resistance and risk of selecting carbapenem-resistant organisms.International label, same formulation · Medicines.org.uk (eMC) / MHRA
• Serious hypersensitivity and severe cutaneous adverse reactions (SJS/TEN/DRESS/AGEP) reported — discontinue if suspected.International label, same formulation · Medicines.org.uk (eMC) / MHRA
• Monitor hepatic function (drug-induced liver injury risk). Antibiotic-associated colitis possible. Seizures reported infrequently with carbapenems. Avoid concomitant valproate (large drop in valproic acid levels).International label, same formulation · Medicines.org.uk (eMC) / MHRA

• Valproic acid / sodium valproate / valpromideMajorCarbapenems can decrease valproic acid levels by 60–100% within about two days — combination should be avoided.Medicines.org.uk (eMC) / MHRA
• ProbenecidModerateCompetes for tubular secretion and increases meropenem half-life and plasma concentration — caution.Medicines.org.uk (eMC) / MHRA
• Oral anticoagulants (e.g. warfarin)ModerateAntibiotics may potentiate anticoagulant effect — monitor INR during and shortly after co-administration.Medicines.org.uk (eMC) / MHRA

• Preferable to avoid during pregnancy as a precaution; limited human data. Animal studies do not indicate direct/indirect reproductive toxicity.International label, same formulation · Medicines.org.uk (eMC) / MHRA
• Small amounts excreted in human milk; use only if potential benefit to mother justifies potential risk to the infant.International label, same formulation · Medicines.org.uk (eMC) / MHRA

• Meropenem: Bactericidal inhibition of cell-wall synthesis by binding penicillin-binding proteins; not active against MRSA/MRSE (US label).